scholarly article | Q13442814 |
P356 | DOI | 10.1093/EURHEARTJ/EHV194 |
P698 | PubMed publication ID | 26033984 |
P50 | author | Michael Bailey | Q41130860 |
David Pilcher | Q46110243 | ||
Carol L. Hodgson | Q48311327 | ||
David J. Cooper | Q57070884 | ||
Daniel Brodie | Q87827918 | ||
Vincent Pellegrino | Q88255248 | ||
Ravi R Thiagarajan | Q88264561 | ||
Matthieu Schmidt | Q114573983 | ||
Carlos Scheinkestel | Q117259428 | ||
Jayne Sheldrake | Q117259432 | ||
Peter T Rycus | Q117259437 | ||
P2093 | author name string | Lloyd Roberts | |
Aidan Burrell | |||
P433 | issue | 33 | |
P921 | main subject | extracorporeal membrane oxygenation | Q1385195 |
cardiogenic shock | Q2477062 | ||
P304 | page(s) | 2246-2256 | |
P577 | publication date | 2015-06-01 | |
P1433 | published in | European Heart Journal | Q2286839 |
P1476 | title | Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-score | |
P478 | volume | 36 |
Q34677347 | 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contrib |
Q90243596 | A Simple Scoring System to Predict Survival after Venoarterial Extracorporeal Membrane Oxygenation |
Q39695029 | A local network for extracorporeal membrane oxygenation in refractory cardiogenic shock |
Q33581752 | Advanced Age as a Predictor of Survival and Weaning in Venoarterial Extracorporeal Oxygenation: A Retrospective Observational Study |
Q94482870 | Advanced Pulmonary and Cardiac Support of COVID-19 Patients: Emerging Recommendations From ASAIO-A "Living Working Document" |
Q56381075 | Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology |
Q88527382 | Advances in critical care management of patients undergoing cardiac surgery |
Q47283268 | Ambulatory central VA-ECMO with biventricular decompression for acute cardiogenic shock |
Q64248937 | An audit of mortality by using ECMO specific scores and APACHE II scoring system in patients receiving extracorporeal membrane oxygenation in a tertiary intensive care unit in Hong Kong |
Q56893227 | Associations between ventilator settings during extracorporeal membrane oxygenation for refractory hypoxemia and outcome in patients with acute respiratory distress syndrome: a pooled individual patient data analysis : Mechanical ventilation during E |
Q38633582 | Cardiac surgery score (CASUS) improves outcome prediction in patients treated with extracorporal life support (ECLS). |
Q94503860 | Cardiovascular Collapse in COVID-19 Infection: The Role of Veno-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO) |
Q90294961 | Chinese society of cardiology expert consensus statement on the diagnosis and treatment of adult fulminant myocarditis |
Q93027580 | Circulating dipeptidyl peptidase 3 and alteration in haemodynamics in cardiogenic shock: results from the OptimaCC trial |
Q92280780 | Clinical Efficacy of Extracorporeal Cardiopulmonary Resuscitation for Adults with Cardiac Arrest: Meta-Analysis with Trial Sequential Analysis |
Q54979160 | Clinical determinants of successful weaning from extracorporeal membrane oxygenation in patients with fulminant myocarditis. |
Q64267162 | Clinical implications of the initial SAPS II in veno-arterial extracorporeal oxygenation |
Q39317396 | Concomitant implantation of Impella® on top of veno-arterial extracorporeal membrane oxygenation may improve survival of patients with cardiogenic shock |
Q55000890 | Cost-effectiveness in extracorporeal life support in critically ill adults in the Netherlands. |
Q37684248 | Duration of veno-arterial extracorporeal life support (VA ECMO) and outcome: an analysis of the Extracorporeal Life Support Organization (ELSO) registry. |
Q37205892 | ECMO Used in a Refractory Ventricular Tachycardia and Ventricular Fibrillation Patient: A National Case-Control Study |
Q37639744 | ECMO in cardiac arrest and cardiogenic shock |
Q89420903 | ECMO use and mortality in adult patients with cardiogenic shock: a retrospective observational study in U.S. hospitals |
Q60950116 | ECMO-treatment in patients with acute lung failure, cardiogenic, and septic shock: mortality and ECMO-learning curve over a 6-year period |
Q37717673 | Early Prediction of 3-month Survival of Patients in Refractory Cardiogenic Shock and Cardiac Arrest on Extracorporeal Life Support. |
Q57126169 | Early enteral nutrition for cardiogenic or obstructive shock requiring venoarterial extracorporeal membrane oxygenation: a nationwide inpatient database study |
Q90470639 | Effect of interplay between age and low-flow duration on neurologic outcomes of extracorporeal cardiopulmonary resuscitation |
Q95940938 | Epidemiology, Pathophysiology and Contemporary Management of Cardiogenic Shock - A position statement from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) |
Q42545181 | External Validation of Survival-Predicting Models for Acute Myocardial Infarction with Extracorporeal Cardiopulmonary Resuscitation in a Chinese Single-Center Cohort. |
Q96135076 | Extra-corporeal membrane oxygenation and Eculizumab: Atypical treatments for typical haemolytic uraemic syndrome |
Q98386253 | Extra-corporeal membrane oxygenation for severe respiratory failure in the UK |
Q94482874 | Extracorporeal Life Support Organization COVID-19 Interim Guidelines |
Q26746652 | Extracorporeal Membrane Oxygenation as a Bridge for Heart Failure and Cardiogenic Shock |
Q94554077 | Extracorporeal Membrane Oxygenation in Cardiogenic Shock due to Acute Myocardial Infarction: A Systematic Review |
Q28071264 | Extracorporeal life support during cardiac arrest and cardiogenic shock: a systematic review and meta-analysis |
Q47653181 | Extracorporeal life support in cardiogenic shock: indications and management in current practice. |
Q48149565 | Extracorporeal membrane oxygenation for poisoning in adult patients: outcomes and predictors of mortality |
Q37646693 | Extracorporeal membrane oxygenation support in post-traumatic cardiopulmonary failure: A 10-year single institutional experience |
Q92008484 | Extracorporeal membrane oxygenation therapy in the COVID-19 pandemic |
Q47108069 | Factors Associated with the Need for, and the Impact of, Extracorporeal Membrane Oxygenation in Children with Congenital Heart Disease during Admissions for Cardiac Surgery. |
Q47133334 | Impact of dynamic changes of elevated bilirubin on survival in patients on veno-arterial extracorporeal life support for acute circulatory failure |
Q64120125 | Important methodological flaws in the recently published clinical prediction model the REMEMBER score |
Q57399045 | In Reply |
Q36765684 | In-hospital mortality and successful weaning from venoarterial extracorporeal membrane oxygenation: analysis of 5,263 patients using a national inpatient database in Japan |
Q61804720 | Interprofessional two-man team approach for interhospital transport of ARDS-patients under extracorporeal membrane oxygenation: a 10 years retrospective observational cohort study |
Q37208712 | Is there light at the end of the tunnel?-new perspectives in ECMO survival. |
Q87994316 | Isolated left ventricular failure is a predictor of poor outcome in patients receiving veno-arterial extracorporeal membrane oxygenation |
Q37724757 | Life-threatening massive pulmonary embolism rescued by venoarterial-extracorporeal membrane oxygenation |
Q33363257 | Liver function during mechanical circulatory support: from witness to prognostic determinant |
Q91607128 | Long-term survival and costs following extracorporeal membrane oxygenation in critically ill children-a population-based cohort study |
Q38648838 | Mechanical Circulatory Support for Decompensated Heart Failure |
Q64231056 | Mechanical Circulatory Support in the Cardiac Catheterization Laboratory for Cardiogenic Shock |
Q30826381 | Microcirculatory assessment of patients under VA-ECMO. |
Q93198462 | Model-Based Weaning Tests for VA-ECLS Therapy |
Q90141233 | Mortality and costs following extracorporeal membrane oxygenation in critically ill adults: a population-based cohort study |
Q65002854 | National trends and outcomes for extra-corporeal membrane oxygenation use in high-risk pulmonary embolism. |
Q93190062 | Neonatal Cardiac ECMO in 2019 and Beyond |
Q38694158 | Noteworthy Articles in 2015 for Cardiothoracic Critical Care |
Q46125420 | Novel prediction tool for veno-arterial extracorporeal membranous oxygenation in acute myocardial infarction patients. |
Q26770310 | Options for temporary mechanical circulatory support |
Q39017618 | Outcome of elderly undergoing extracorporeal life support in refractory cardiogenic shock |
Q54964671 | Outcomes in Cardiogenic Shock Patients with Extracorporeal Membrane Oxygenation Use: A Matched Cohort Study in Hospitals across the United States. |
Q64251627 | Outcomes of venoarterial extracorporeal membrane oxygenation for refractory cardiogenic shock: systematic review and meta-analysis |
Q46276325 | Pediatric Extracorporeal Life Support Organization Registry International Report 2016. |
Q49950489 | Position paper for the organization of ECMO programs for cardiac failure in adults |
Q38631238 | Postoperative management of heart failure in pediatric patients |
Q64245580 | Predicting clinical outcome in patients undergoing VA-ECMO |
Q90428437 | Predicting mortality after postcardiotomy venoarterial extracorporeal membrane oxygenation |
Q60911598 | Predicting mortality in patients undergoing VA-ECMO after coronary artery bypass grafting: the REMEMBER score |
Q57479596 | Predictors of Survival for Patients with Acute Decompensated Heart Failure Requiring Extra-Corporeal Membrane Oxygenation Therapy |
Q97537997 | Predictors of survival following veno-arterial extracorporeal membrane oxygenation in patients with acute myocardial infarction-related refractory cardiogenic shock: clinical and coronary angiographic factors |
Q38600946 | Prognostic indicators of survival and survival prediction model following extracorporeal cardiopulmonary resuscitation in patients with sudden refractory cardiac arrest. |
Q88711670 | Shock Management for Cardio-surgical Intensive Care Unit Patient: The Silver Days |
Q98466838 | Short-term mechanical circulatory support (intra-aortic balloon pump, Impella, extracorporeal membrane oxygenation, TandemHeart): a review |
Q47338687 | Single-centre experience with the Impella CP, 5.0 and RP in 109 consecutive patients with profound cardiogenic shock. |
Q91644956 | Temporary Mechanical Circulatory Support in Acute Heart Failure |
Q97589339 | Temporary circulatory support for cardiogenic shock |
Q40042007 | The ENCOURAGE mortality risk score and analysis of long-term outcomes after VA-ECMO for acute myocardial infarction with cardiogenic shock |
Q64251633 | The Extracorporeal Life Support Organization Registry: update and perspectives |
Q30234573 | The ICM research agenda on extracorporeal life support |
Q39799745 | The Impact of Renal Failure and Renal Replacement Therapy on Outcome During Extracorporeal Membrane Oxygenation Therapy |
Q47552207 | The Initial Evaluation and Management of a Patient with Heart Failure |
Q42041408 | The Need for Extracorporeal Membrane Oxygenation in Adults Undergoing Congenital Heart Surgery: Impact and Trends of Utilization. |
Q58707960 | The Role of Echocardiography in Neonates and Pediatric Patients on Extracorporeal Membrane Oxygenation |
Q30491215 | The challenges in predicting ECMO survival, and a path forward |
Q47415870 | The impact of severity of initial illness, determined by SOFA score, and presence of anemia on outcomes among patients requiring Extra Corporal Membrane Oxygenation (ECMO) support: A single center experience |
Q39261028 | The modified SAVE score: predicting survival using urgent veno-arterial extracorporeal membrane oxygenation within 24 hours of arrival at the emergency department |
Q92158475 | Therapeutic Advances in the Management of Cardiogenic Shock |
Q55412673 | Vascular complications in adult postcardiotomy cardiogenic shock patients receiving venoarterial extracorporeal membrane oxygenation. |
Q47278862 | Veno-arterial extracorporeal membrane oxygenation in addition to primary PCI in patients presenting with ST-elevation myocardial infarction |
Q39342710 | Venoarterial extracorporeal membrane oxygenation for refractory cardiogenic shock post-cardiac arrest |
Q36653630 | Venovenous Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome in Adults: Prognostic Factors for Outcomes |
Q42332758 | What is extracorporeal cardiopulmonary resuscitation? |
Search more.